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Background: Patients on oral anticoagulant therapy (OAT) require regular testing of the prothrombin time (PT)
and the international normalised ratio (INR) to monitor their blood coagulation level to avoid complications of
either over or under coagulation. PT/INR can be tested by a healthcare professional or by the patient. The latter
mode of the testing is known as patient self-testing or home testing. The objective of this study was to elicit
patients’ perspectives and experiences regarding PT/INR self-testing using portable coagulometer devices.
Methods: Internet blog text mining was used to collect 246 blog postings by 108 patients, mainly from the USA
and the UK. The content of these qualitative data were analysed using XSight and NVivo software packages.
Results: The key themes in relation to self-testing of OAT identified were as follows: Patient benefits reported were
time saved, personal control, choice, travel reduction, cheaper testing, and peace of mind. Equipment issues
included high costs, reliability, quality, and learning how to use the device. PT/INR issues focused on the frequency
of testing, INR fluctuations and individual target (therapeutic) INR level. Other themes noted were INR testing at
laboratories, the interactions with healthcare professionals in managing and testing OAT and insurance companies’
involvement in acquiring the self-testing equipment. Social issues included the pain and stress of taking and
testing for OAT.
Conclusions: Patients’ blogs on PT/INR testing provide insightful information that can help in understanding the
nature of the experiences and perspectives of patients on self-testing of OAT. The themes identified in this paper
highlight the substantial complexities involved in self-testing programmes in the healthcare system. Thus, the
issues elicited in this study are very valuable for all stakeholders involved in developing effective self-testing
strategies in healthcare that are gaining considerable current momentum particularly for patients with chronic
illness.
Background
The development of the effective empowerment of
patients through “more rights and control over (their)
health and care” has been strongly suggested in recent
years [1], which could provide increased control and
choice to patients regarding the selection of a particular
therapy, and an appropriate healthcare setting as well as
the use of a particular medical device technology. By
these means, patients could take control of and manage
some key health related issues themselves. These might
include important aspects of self-caring, self-monitoring
and self-management. For example, self-monitoring of
oral anticoagulation therapy by patients themselves
could lead to their greater independence with less
inconvenience [2].
Anti-coagulant therapy
Oral anti-coagulant therapy (OAT) is indicated for sev-
eral medical conditions such as atrial fibrillation (AFib),
mechanical heart valve prostheses, deep vein thrombosis
(DVT), pulmonary embolism (PE), and stroke [3]. It has
however been particularly recommended for patients
and especially the elderly who may have or be at risk of
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boses [4]. The OAT has a narrow optimum range
designed to prevent the major adverse health effects of
both over- and under- coagulation; therefore, regular
monitoring of OAT, both in terms of the dose and the
frequency of administration, is required [5]. The moni-
toring of OAT is done by checking the prothrombin
time (PT) and the international normalised ratio (INR)
of the patient taking an oral anticoagulant. These two
terms: PT and INR are important from the clinicians’
and patients’ perspectives because they show the blood
coagulation level; therefore, they provide a measure of
whether the blood coagulation level is stable (which is
generally called the therapeutic or target level and thus
is desirable) or variable (whether it has gone up or
down with the extent of variation determining the need
for medical intervention). Thus, it is important that the
context of both PT and the INR terms be set out.
Prothrombin Time
The prothrombin time is the time taken, in seconds, for
the patient’s plasma to clot in an extrinsic pathway of coa-
gulation, which is most commonly measured for monitor-
ing OAT through warfarin for example [6]. The reference
values for PT may vary between laboratories [7].
International Normalised Ratio
The World Health Organisation’s expert committee
on biological standardization [8] has defined the inter-
national normalised ratio through the following
calculation:
INR = (PT patient/MNPT)
ISI
W h e r eP Tp a t i e n ti st h eP Tf o rt h ep a t i e n t ’s
blood; MNPT is the mean normal prothrombin
time (MNPT) of the healthy adult population, and
ISI is the international sensitivity index (ISI) of the
system [3].
An INR value of 1 is regarded as normal. Though a
precise target INR value for each medical condition may
be somewhat different, an overall target INR value of
2.5 is recommended for most medical conditions requir-
ing OAT [5].
OAT monitoring
The PT and the INR of patients stable on OAT is
usually checked at the healthcare facility by healthcare
professionals or at home by the patient or by his/her
care provider. Monitoring in hospitals is undertaken,
usually in an anticoagulation clinic or in an haematology
department, at 4-6 week intervals [5] while the fre-
quency of monitoring of PT/INR at home may vary
from one patient to another.
I nt h ec a s eo fs e l f - t e s t i n g ,the patient is informed by
his/her general practitioner or the anticoagulation clinic
doctor or nurse about the target therapeutic range of
his/her (patient’s) PT/INR. Consequently, the patient
tests his/her PT/INR level and reports the results to his/
her clinician, who interprets the PT and the INR values,
adjusts the dose of the oral anticoagulant drugs, and
informs the patient about the new dosage. Self-testing of
the INR and the PT is performed with a hand held
device known as coagulometer.
Coagulometers
Coagulometer devices are broadly divided into two cate-
gories i.e. monitors for patient self-testing, which are
small, portable and require capillary whole blood taken
by finger pricking, and monitors for professional use,
which are large and multifunctional [4]. Generally the
former type of monitors are intended for the patient’s
use (either by patients themselves or by their carers)
while the latter type of monitors are intended for use by
healthcare professionals such as haematology doctors
and nurses in a primary, secondary or tertiary healthcare
facility. At present, there are a number of commercially
available coagulometers and some of them have been
specifically evaluated in the UK [5] and a few types of
coagulometer devices have been approved for home use
in the USA [3].
Recently, there has been increase in the availability and
use of coagulometer devices for testing the PT and the
INR of patients taking oral anticoagulants such as war-
farin [9]. These devices can be used in different settings
(e.g. hospitals in both primary and secondary care), care
homes, private homes and at any place) and by different
types of users (e.g. healthcare professionals, patients and
carers) [10]. However, the effectiveness of this type of
device varies and depends on the user (operator), envir-
onment and circumstances in which they are used [11].
The settings in which the device is used and characteris-
tics of users, particularly those of patients, may have
important implications for the safe, effective and
intended use of the device. This is because OAT is given
in several medical conditions such as AFib, mechanical
heart valve prostheses, DVT, PE, and stroke [3] The
needs and requirements of such patients might be very
different due to differences in not only in their medical
conditions but differences in their age, gender, culture,
skills, training, physical abilities, cognition and capabil-
ities [12,13]. The study of the needs and requirements of
different types of end users of coagulometer devices for
home use would thus help in understanding various
important issues with respect to self-testing of OAT.
The overall aim of this study was to elicit patients’
perspectives and experiences on self-testing of PT/INR
using portable coagulometer devices.
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Blogs as a data source
The Internet, particularly in relation to blogs, has
emerged as an important source of information on var-
ious issues relating to health, medical therapy and medi-
cal device technologies. ‘Blog’ is a shortened form of
weblog, which stands for wee-blog, and is defined as a
webpage that is regularly updated with postings by blog-
ger(s) in a dated order [14,15]. Blogs can provide first
person narratives from different communities such as
patients and their lay carers who otherwise may be
infrequently assessed through some conventional
methods [16].
Through blogs, patients can share their experiences
and exchange information with other people regarding
various aspects of health and healthcare such as the ill-
ness, medication and medical devices that can be used
for self-testing and diagnostic purposes [17].
Due to the valuable information available on patients’
blogs, a number of studies have used patients’ blogs as a
primary source of data, mainly qualitative in nature, on
patients’ perspectives regarding different medical condi-
tions. For example, studies have been undertaken of
patients with Alzheimer’s disease [18], with pro-anorexia
[19,20], with sexual health problems [21] and with var-
ious types of cancers [22-24]. There are however both
advantages and limitations in using the Internet as a
source of data [24]. The advantages of using the Internet
include it being an easy, quick and inexpensive tool for
collecting actual primary research data, through online
and email surveys [25], and the ability to compile
already available data existing in different forms such as
text, audios, videos, images and so on [20]. However,
most bloggers use nicknames or remain anonymous,
and whilst it is difficult to identify them personally, one
of the strengths of the data from blogs is that the anon-
ymity of the bloggers is normally assured [26]. Other
advantages of using the Internet as a data source can
include the greater protection of human subjects
through the process of anonymity, and through these
publicly available documents, the avoidance of the cum-
bersome and time-consuming process of acquiring for-
mal ethical approval for involving patients in direct
primary research [16]. This however does not mean that
using data from the Internet is devoid of ethical
considerations.
In fact, a number of ethical considerations concerning
the reporting of data obtained from the Internet have
already been discussed and reported at great length by
others [27-29]. There is however a growing consensus
among researchers that if Internet data is freely and
publicly accessible then it can be used for considered
research without prior approval [21,24]. On this
premise, data taken from the Internet have in fact been
widely used already [24].
We however acknowledge that there are a number of
limitations of using the Internet blogs as a research data
source. The limitations may include the use of the nick-
names and a feigned identity, age, gender and place of
location by the bloggers. This might be due to the fact
that bloggers want to be especially certain of their anon-
ymity [30,31]. It is therefore very difficult to verify blog-
gers’ demographic details [32] and thus be able to
compare findings with a comparative population sample.
In addition, one may argue that the issue of biased sam-
pling may arise in using Internet blogs because access to
the Internet is not available universally across all ages,
gender and social classes [33]. However, the digital
divide is decreasing and the access to the Internet is
increasing among increasing strata of the population,
such as both young and old people, as well as men and
women, especially in developed countries such as the
United Kingdom (UK). For example, a recent survey of
access to the Internet in the UK revealed that the Inter-
net was used in the last three months by 79% of men
and 75% of women of all ages including 72% of people
aged 55-64 years and 32% of people aged ≥65 years [34].
The same survey reported that the Internet was used
(almost) daily by 74% of 55-64 year-olds and 59% of
those aged ≥65 years [34]. In addition, the Internet was
used for social networking and blogging by 44% of men
and 42% of women, including 19% of 55-64 year-olds
and 8% of those ≥65 years [34]. Another important issue
in analysing the Internet data from patients’ perspectives
is the difficulty in selecting ‘real’ patients, and identify-
ing and excluding bloggers who may have a commercial
interest for participating in blog discussions. For exam-
ple, there is evidence that commercial companies are
using blogs to elicit customers’ views on their products
[15,35]. In such a situation, a way forward may be the
careful swotting of both very negative and very positive
blog posts about the theme or the product (in our case
a handheld medical device for self-testing of blood coa-
gulation level). This is the approach we adopted in iden-
t i f y i n gw h a tw ec o n s i d e r e dt ob ear e a l i s t i cp i c t u r eo f
patients’ views on the self-testing of blood coagulation
levels through the Internet blog posts. Other limitations
of data from blogs can be the arrangement of blog post-
ings in chronological order rather than on the basis of
the importance and content [36]; therefore, more rele-
vant blog postings might not be retrievable easily. Some-
times, information provided in blogs can be erroneous
and misleading [37], which can raise issues of the qual-
ity of blogs data [26]. Therefore, researcher(s) need to
separate blogs containing factual information from those
containing misleading information, which can be verified
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The Google blogs search engine was used to find
patients’ blogs on self (home) PT/INR testing. The Goo-
gle blog search was selected and used for a number of
reasons. For example, it allowed facilities such as search-
ing blogs and posts by title, by numbers of words, or at
least one word, by the exact phrase, as well as by URL,
authorship, language and date. A filtering facility for
safe searching to avoid retrieving any malicious blog
post or other material was also available.
Inclusion criteria
Blogs and blog postings written in the English language
from January 2000 to October 2009 by any patient or
lay carers were selected. Another criterion for the selec-
tion of blogs was that they should be currently active.
Exclusion criteria
Blogs and posts written and posted by people other than
patients, such as manufacturers, clinics, healthcare pro-
fessionals and others were excluded. Marketing articles
or promotional materials regarding PT/INR testing were
also excluded. No research studies based on primary
and secondary research including randomised controlled
trials and literature reviews were included. Blogs that
were currently inactive were also not included.
Keywords
The following keywords and phrases were used to
search the relevant blogs: INR, patient, anticoagulation,
monitoring, self-testing, point of care testing, oral antic-
oagulant, home, warfarin therapy (Table 1). These key-
words were word searched using ‘AND’ and ‘OR’
connectors. The keywords were searched first in the
blog title and then in the post title, followed by ‘the
exact phrase’,a n dt h e n‘with all of the words’ and ‘with
at least one of the words’ in the blog and the post. We
did not search for blogs and posts written by any parti-
cular author; therefore, this option available in the Goo-
gle blog search was left blank. We did not list blogs
under specific URLs; thus, this option was also not used
during searches.
Search results
Searches of the aforementioned keywords resulted in
3653 hits (Table 1). After deleting duplicates and irrele-
vant hits, 246 relevant blog postings that were posted by
108 patients, mainly from the USA and the UK, were
collected from different blogs, mainly in discussion
groups on PE, DVT, heart valve replacement (HVR) and
PT/INR self-testing equipment.
A blog on PT/INR self-testing equipment provided 50
postings of which 12 were posted from January 2005 to
August 2005 and 38 were posted from January 2008 to
October 2009. A blog on HVR through different threads
linked to the blog provided 111 posts between August
2005 and October 2005. A blog on home anticoagula-
tion monitoring provided 12 posts uploaded from Janu-
ary 2009 to March 2009. A blog on pulmonary
embolism contained 31 posts in two different threads
i.e. ‘PT/INR home test’ had 25 posts placed from
December 2008 to January 2009 and ‘fluctuating INR’
had six posts uploaded from January 2008 to September
2009. Another blog on home INR monitoring provided
seven posts dated from March 2008 to April 2008.





INR AND Testing 3
INR AND patient 5
INR AND patient AND selftesting 1
INR AND patient AND self testing 2
self INR testing 1
patient INR testing 1
point of care testing AND INR 3
INR AND point of care testing 1
home INR 1,663
home INR testing 13
In blog posts
Home INR testing 8
“INR self testing"* 5
“INR home testing” *2
“INR home monitoring"* 2
“anticoagulation self monitoring” *1
“oral anticoagulant monitoring"* 1
“anticoagulation monitoring"* 91
“anticoagulation self monitoring"* 1
“warfarin therapy"* 1,398
In post: “warfarin therapy"* + In post title: patient 22
In post: “warfarin therapy"* + In post title: patient testing 5
In post: “warfarin therapy"* + In post title: home testing 11
In post: “warfarin therapy"* + In post title: self testing 1
In post: testing INR + In post title: self 16
In post: testing INR + In post title: patient 31
In post: testing INR + In post title: home 86
In post: testing INR + In post title: patient blog 7
In post: testing INR + In post title: self blog 3
In post: testing INR + In post title: blog 213
In post: “INR home testing"* + In post title: blog 2
In post: “home testing” * + In post title: blog. 3
In posts and blog title
In post: “warfarin therapy"* + In blog title: patient 2
Total 3653
*Searched as a phrase.
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ary 2009 were collected from different threads to a blog
on deep vein thrombosis. In total, 246 postings were
collected from the six blogs.
Ethical issues
Blogs that we accessed were from open access sites and
did not require any formal approval to access to the
content of the postings available there; however, post-
ings required registration to take part in the discussion
and submit a post. As the content of these blogs was in
the open public domain, we therefore did not seek any
approval prior to accessing the content of these blogs, a
strategy agreed by other academic researchers [24].
We collected textual data from the open access Inter-
net blogs without the prior consent of the bloggers to
study their viewpoint and experiences regarding self-
testing of OAT. However, we obtained the ethics
approval from the Research Ethics Committee at the
Department of Information Systems and Computing at
our University. The ethics committee advised us that
the range of ethical implications were far more
restricted compared to most patient based research
because we were analysing information that was already
placed in the public domain, which meant that the
information being reported in this study was secondary
data. The Research Ethics Committee however observed
that the data should be reported anonymously. We have
therefore reported the data anonymously and at the
group level rather than at an individual level.
Data analysis
Qualitative research methods are required in situations
that require in depth investigation and an understanding
of process to determine the exact nature of the issue
being investigated, especially when the data are available
in non-numeric form e.g. through text or through visual
means [38]. We undertook qualitative content analysis
of the data, which we collected in text form from blog
postings. Validation of qualitative content analysis can
be achieved through using software packages [39]; in
this case we used two software packages i.e. XSight ver-
sion 2 ( trial version) and NVivo version 8 (http://www.
qsrinternational.com) to analyse the data because quali-
tative data analysis cannot easily be undertaken using
single piece of software [38]. Another advantage of com-
puter assisted content analysis of textual data is the cod-
ing reliability that helps in generating comparable results
[40]. The data analysis was undertaken in a number of
stages. As a first step, all data from selected blogs were
saved as html files along with the details (e.g. nick-
names) of bloggers. In the second step, data from the
html files were saved as a single file in Microsoft word.
In the third step, all data were imported into NVivo
software and the frequency of most commonly used
words was ascertained after removing the details of
bloggers, dates, numbers and the most commonly used
English words. Thereafter, a word cloud of the most
commonly used words in the blogs’ text was created as
shown in Figure 1 (This was created in the Wordle - a
Java applet, which is available at http://www.wordle.net/).
This process helped us in identifying some key terms and
themes relevant to blood coagulation testing as well as
ensuring the suitability and relevance of the text of the
blogs for the study objectives. In the fourth step, the text
of all blog postings was read and issues such as the bene-
fits, limitations, safety, training, cost, purchasing, mainte-
nance and communications with healthcare providers
were noted and a map of these issues (Figure 2) was cre-
ated in XSight software, which helped in categorising the
findings of this study.
Results
The formal demographics, location and other details
were not available for all bloggers from blog postings
that were collected for this study; therefore, this infor-
mation, helpful though it might have proved, is not
reported here.
Qualitative analysis of the content of the collected
blog postings resulted in the identification of seven
themes, which, in no particular order, were on patient
benefits, equipment related issues, managing PT/INR,
laboratory testing, interaction with healthcare providers,
insurance and social issues (Figure 2). Findings for each
of the themes are presented as follows.
Patient benefits
The benefits from self-testing were indicated to be time
saved, travel reduction, personal control, choice and
freedom, cheaper testing, and peace of mind. In report-
ing the benefits of having a self-testing coagulometer,
one of the UK based participants wrote that the device
would save his time as well as avoid a journey to the
clinic for testing that he would not be able to make
because of his ill health. He stated that it would also
reduce the costs of the NHS (National Health Service -
public sector healthcare providing service in the UK)
due to fewer appointments. Reporting self-testing advan-
tages such as cheaper testing and freedom of testing
anywhere, a patient wrote that he has bought a self-test-
ing device because he was going on holiday to a country
where the cost of one PT/INR test was between £30 and
£40.
A number of participants did not want to go to the
hospital clinic for PT/INR testing for various reasons.
For example, a female patient who did not like to travel
to the clinic for testing wrote that she did not like going
to see her doctor every other day therefore she would
l i k et oh a v eac o a g u l o m e t e ra n dp e r f o r mt h eP T / I N R
testing at home. Similarly, another patient, who had a
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Figure 2 Map of patients’ perspectives on self-testing of oral anticoagulation therapy reported in patients’ Internet blogs.
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would like to perform home testing compared to going
every couple of weeks to a clinic for the testing because
it was time consuming. A participant who was on
heparin for a year wrote, “It would have been so useful
to have a home machine, instead of having to visit the
labs all the time.” Another participant was interested in
self-testing because she had to wait for at least two
hours every week during testing at the clinic, which she
did not like.
Given the freedom of self-testing with a portable coa-
gulometer, a patient said that he wanted to buy the
device because his INR could become suddenly very
unstable and he could not get to the hospital because of
ill health. In addition, this patient liked self-testing
because it is undertaken by finger pricking and he dis-
liked hospital based testing which requires drawing
venous blood by needles, which he cannot handle.
A participant in favour of having a self-testing device
wrote, “I can also check at any time, especially if feeling
ill.” Another wrote, “I was so excited to be doing home
testing and having control of over this part at least.”
Given the possibility of self-testing over a longer period,
a patient wrote that he had been performing self-testing
for about two years. However, one of the participants
was surprised to know about the possibility of self-
testing. She wrote, ‘I had no idea such a service (i.e. INR
self-testing) was available.”
One of the participants wrote that having a device is
good value for money. Another patient believed that
self-testing was the future. However, one of the partici-
pants wrote that she was thrilled on getting a device but
became less confident after getting it.
Equipment issues
Issues raised relating to the PT/INR self-testing device
were high cost, reliability and quality, calibration, lack of
confidence in accuracy, different makes and models, places
to buy devices, and training in how to use the device.
T h em o s tf r e q u e n t l yc i t e di s s u ei nr e l a t i o nt ot h e
equipment was the cost of the device and the test strips
that were needed. A number of participants wrote that
the device was expensive. They even compared the cost
of a coagulometer with a glucometer and said that the
former was more expensive then the latter. A participant
wrote that the device cost plus the maintenance cost was
a lot to spend for a service which can be provided free by
a community nurse visiting at home. Another participant
wrote that when the device price comes down she would
do self-testing. This showed that some patients might be
interested in PT/INR self-testing but are held back due
to the high cost of the equipment. Another participant
wrote that the cost incurred on the device can be claimed
back effectively through paying less tax and from an
insurance claim. This might be context specific, in that
these points are more particular to individual healthcare
systems funded in different ways, such as that in the USA
compared to the UK. Regarding test strips, a participant
said that he could get the strips though a clinician’sp r e -
scription, while another participant wrote that he was
waiting to hear from his doctor about the test strips,
which he thought were very expensive.
A number of participants wrote that home testing was
more expensive than the alternatives. One of them said
that the cost of single home test would be about US$
9.00 and another wrote that the cost of self-testing
could be high depending on the frequency of testing.
One participant wrote that he has a second hand
device, which he bought at half price. However, there
was no discussion on the performance and reliability
issues in using a second hand device. Nonetheless, in
raising the issues of the reliability of self-testing devices,
one of the participants asked whether there was any
accuracy problem.
A few participants wrote that the devices need to be
calibrated and one takes his device to the laboratory for
checking every six months. Another wrote that he took
his device to his cardiologist’s office and they took sev-
eral weeks to get it right.
One of the participants asked ‘is there only one manu-
facture making them?” A few participants replied and
some said there was only one manufacturer and others
said there were a number of the manufacturers. A parti-
cipant asked, “What is the best brand/model to use?” In
response to this question, the names of a few makes/
models were mentioned. One of the participants wanted
to know where one could buy the best device. A few
participants replied that they bought the devices directly
from the manufacturers.
Training
Regarding training in how to use an INR testing device
and how to perform a test, one of the participants wrote
that he had some literature and a demonstration video
but he thought he still needed further training, which
was going to cost him about £120, though this was less
than his anticoagulation clinic would charge. Another
participant wrote that training is provided; however, the
details of the training provider were not mentioned.
Nevertheless, a patient wrote “absolutely brilliant and
easy” about the use of the device. A female participant
h o w e v e rs a i dt h a ts h ed o e sn o th a v ec o n f i d e n c ei nt h e
r e s u l t so fh o m et e s t i n gb e c a u s et h er e s u l t sw e r ed i f f e r -
ent from laboratory results.
Laboratory testing
A few participants wrote about their experience of
INR testing at hospital clinics and laboratories.
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wrote, “I ... hated it.....Also had to wait at least 2 hours
to be seen every week.” Another wrote that having INR
test at a lab was inconvenient as well as costly. The
same participant also mentioned that getting feedback
from the lab about what to do next was also difficult.
A participant wrote on his frustration about the cancel-
lation of his lab test appointment, changes in testing fre-
quency and anticoagulant dose as well as getting a new
appointment and medication and contacting the doctors,
the pharmacy and the laboratory.
However, some of the participants were in favour of
INR testing at a lab as one participant wrote that having
INR tested at the lab is advantageous because they con-
trol many more variables - which were however not
described. One patient wrote that the results of INR
testing by herself were about 0.4 higher compared to
the lab results. The same participant also wrote that
INR test results vary between laboratories. Patients com-
pared PT/INR results of self-testing with laboratory
based testing. In this regard, a participant wrote that
soon after having an INR tested at the lab he performed
self-testing to check the accuracy between the two.
Managing PT/INR
Issues in managing PT/INR comprised the frequency of
testing, fluctuations and the target (therapeutic) INR
level and communicating INR self-test results.
Testing frequency
A female participant with a HVR wrote that she was
testing every week at home and every three weeks at
laboratory. While another patient said, “Iw o n ’tb et e s t -
ing daily - probably 1-2/week may be spaced out further
if I ever get my levels stable.” A patient who had PE
wrote that her PT/INR was tested twice a week while
the other patient suffering from same medical condition
was going to the clinic in the next four weeks for the
testing. A male participant with DVT was tired of
weekly testing. He wrote, “Next INR test in two week,
finally! Nuff of this once a week test.” Conversely, a par-
ticipant wanted to test more frequently but her clinic
d i dn o tw a n th e rt od ot h a t .O nt h i ss i t u a t i o n ,s h e
wrote, “I get tested once a week, and I have had nurses/
doctors tell me I can wait btwn (between) 2-4 wks
(weeks) to test again, but I don’t feel comfortable.”
INR Level
Participants exchanged their views on normal and indi-
vidual therapeutic levels of the INR. One of them wrote,
“It h i n k‘normal’ is 1.” Another wrote that the range of
his INR was 2-3. A male participant with PE wrote that
the therapeutic rage of his INR has to be between 2.5
and 3.5 but it had never been at the required level in
the last 13 months. While another participant wrote, “I
am almost always in 2-3 range.”
Writing on fluctuations in the INR level, a participant
wrote “I have noticed that the first (test) of spring or
fall - it tends to go up to high or down to low.” Partici-
pants wrote about the effect of diet especially green sal-
ads, vegetables high in vitamin K and the wine on the
INR level. Given frequent fluctuations and INR levels up
to 4.6, one participant wrote, “I’mw o n d e r i n gi fi t
wouldn’tb eag o o di d e at oh a v eah o m et e s t i n g
machine.”
In addition, participants wrote about oral anticoagu-
lants dosage adjustment in the light of INR fluctuations.
One of the participants was unable to determine how to
adjust Warfarin dosage. On this situation, a participant
wrote, “They (anticoagulation clinic) adjust the dosage if
INR was high or low” and another suggested that, “Dos-
ing is based on the lab results.”
Communicating INR results
Ap a r t i c i p a n tw r o t et h a t ,“My clinic calls me and
r e m i n d sm et ot a k em yI N Rt e s tt h ed a yb e f o r ei ti s
due”. He further wrote that after performing a home
test, “I call them (anticoagulation clinic) back with the
results the following day.” Another female patient with
HVR wrote that she keeps her cardiologist’s office
updated with home PT/INR test results. While a partici-
pant wrote that, she informs her clinic about home test
results only when the readings change so that they can
adjust the dose. Regarding keeping a record of self-test-
ing results, a participant wrote that she maintains a
diary as a memento.
Interaction with healthcare providers
With regard to difficulty in communicating with doctors
in managing and testing OAT, a participant suggested
that patients do not deserve extreme stress and they can
change the doctors if they are not communicating well.
In addition, some of the participants wrote that they feel
nervous when they have an appointment with their hae-
matologist or doctor.
Insurance issues
Patients exchanged views on the difficulty in interac-
tions with insurance companies’, especially in acquiring
the self-testing equipment for themselves (patients).
Some of the participants reported a long waiting time
in getting a device through their insurance provider.
A number of patients reported that their insurance
covers purchase of a testing device and the test strip,
which was however not universal but dependent on
the patient’s medical condition. However, some of the
participants were not knowledgeable about this issue
such as a patient with HVR asked, “Does your center
promote the use of these (self-testing devices) for pros-
thetic valve patients? I was approved because of my
valve.”
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Blogs participants discussed on some other issues such
as their main illness and co-morbidities, anticoagulant
drugs, social and psychological issues as follows.
Primary medical conditions and co-morbidities
Participants informed each other about the disease(s)
that they had. A male participant wrote, “Ih a v ea f i b
(Atrial fibrillation).” Another wrote, “It o oa ml i v i n g
with AFib.” The same patient wrote, ‘I am on Coumadin
secondary to atrial fib/flutter and prosthetic valve.” One
of them wrote, “I had a Mechanical Mitral Valve
implanted a couple of years ago.” A male participant
who went to a hospital due to back pain, which he
described as nasty, wrote, “That’sw h e nId i s c o v e r e dm y
PE (pulmonary embolism).” A female participant wrote,
“I’m glad I at least know what caused my DVT and how
to manage it now/prevent another.” Some of the partici-
pants had more than one disease as one of them wrote
that she was hospitalised for a PE but also had liver and
kidney problems.
Anticoagulants
Participants exchanged views on various types of antic-
oagulant drugs and their dosage. A patient having a PE
wrote that the dose of her anticoagulation therapy had
tripled in 3 months. While another participant said that,
she had stopped taking an anticoagulant drug and her
INR level dropped to 1.5, which according to her was
below her therapeutic range of 2. Consequently, she was
worried and asked other participants whether this fall in
the INR was OK! One of the participants replied that
the drug would not raise the INR but it would be better
to talk to the doctor.
Given the possibility of being on anticoagulant therapy
for life, a participant was frustrated and wrote, “Ia mo n
Warfarin (Coumadin) for life. Does it make some
sense?” One of the participants replied that extra pre-
cautions were required while taking it. Another partici-
pant wrote that one of his friends had been taking this
drug for the last ten years and monitoring the INR and
had no problems; however, he cautioned that the drug
needs close attention. One of them wrote that patients
who are sensitive to the oral anticoagulants for example
Warfarin, might be given other anticoagulants such as
Heparin. In addition, a participant wrote that she has
heard about a new drug in the market that requires less
monitoring. The name of the new drug was however
not reported.
Social and psychological issues
The participants raised a number of social and psycho-
logical issues. For example the pain, the stress, distress
and disappointment that they faced during PT/INR
self-testing, taking anticoagulant drugs, acquiring a coa-
gulometer device, visiting an anticoagulation clinic/
laboratory as well as communicating with their doctors,
nurses, pharmacists and the insurance companies in
relation to their anticoagulant therapy and its monitor-
ing. A participant wrote that she felt her whole body
was clotted after taking on oral anticoagulants. Another
patient with PE wrote that sometimes she feels severe
pain that makes her extremely nervous. A number of
participants wrote that they can bear a finger pricking
but they do not like needles for drawing their blood for
INR testing.
Some participants showed their frustration with the
possibility of taking OAT for life. A participant with PE
was afraid and scared of a higher or lower level of his
INR and wrote, “This has been a very scary experience
no doubt!” A few of the participants with PE sometimes
felt severe pain that made them extremely nervous;
hence, they wanted to know more about the origin of
the PE and the reasons behind the severe pain. One of
them having PE and DVT wrote, “I’ve had some really
weird and sharp pains. Not lasting very long though but
it’s quite scary.”
Participants in blogs felt joy in sharing the experience
and communicating with others bloggers. One of them
wrote, “Ia ms og l a dt of i n dt h i s . . .a n dt a l kt oo t h e r s
who have been through it. I have been solo for 2 years.”
In addition, they shared other social issues such as tra-
velling abroad and the joy of visiting new places despite
having health problems. They provided encouragement
and advised each other to relax to avoid the stress, due
to the illness, that might make the things worse. In
addition, they appreciated each other such as a partici-
pant wrote, “Thanks for the advice and support.”
Discussion
The Internet in general and social media sites such as
blogs in particular are increasingly becoming areas of
academic interest because expressions of personal views
and thoughts on key themes can be analysed by increas-
ingly sophisticated methods. The Internet has provided
a formal voice to those who may otherwise be unheard,
or only heard locally. In addition, most of the people
who have access to the Internet use it for either gaining
information or exchanging their experiences on a wide
range of issues such as healthcare and medical device
technologies. Whilst there are always issues of represen-
tativeness in analysing such material the increasing ubi-
quity and availability of this medium to many, increases
the opportunity for more widely applicable findings. It
should also be noted in particular that those who may
be disadvantaged by other means of social communica-
tion, through illness or disability, find considerable
advantages in the use of such media.
The novelty of this study is that it focuses on the
patients in relation to PT/INR self-testing whereas pre-
vious studies, discussed below, were focused on the
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of self-testing compared to laboratory testing of PT/
INR. This study has reported qualitative analysis of
patients’ experiences and opinions as revealed in their
own narratives expressed, without any interference from
the researcher, in the form of weblog postings regarding
self-testing, also known as home testing, of OAT.
Generally, results show that the blogging patients
shared their experience of PT/INR testing mainly in two
biggest healthcare systems i.e. the US healthcare system
and the NHS in the UK.
The findings reveal that the users, through their com-
ments, see a number of advantages in the self-testing of
OAT such as the saving of time, reducing travel, and
reducing other costs involved in visiting health facilities
for PT/INR testing; increasing control over their perso-
nal health and enhancing personal choice in the selec-
tion of the mode of the testing. This is in line with what
has already been reported in the literature using a range
of other methods. For example, patient self-monitoring
provides independence and convenience to patients [2].
The advantages of PT/INR self-monitoring overall are
often seen as including improving healthcare resource
allocation by freeing time for both physicians and
laboratory personnel and better management of OAT;
thus, reducing chances of the complications directly
associated with being outside the standard therapeutic
range [3].
However, self-testing could not be undertaken by
every patient on OAT but only by a tiny minority of
patients [2], who qualify for the formal professional
standards required to allow them to proceed to self-
testing [41]. Even for those who qualify for self-testing
there are requirements for training and quality control
[3] as well as more generally encouragement, self-moti-
vation to ensure adherence to protocols. Otherwise,
patients might stop undertaking self-testing, which,
amongst other consequences, would lead to a loss of
the investment in the testing equipment and training.
Whilst training may be provided in the form of a
demonstration for several minutes, this might not be
enough for some patients as indicated in the blogs’
postings reported in this paper. Therefore, as indicated
in other studies, patients need proper training both the-
oretical and practical to ensure the safety and effective-
ness of the testing regime [5], which would almost
certainly require standardized and monitored training
procedures [2].
There are no exact figures of the numbers of patients
undertaking self-monitoring of their INR. There are
however consistent anecdotal reports that only 1-2% of
people on OAT may be using coagulometers for INR
self-testing, despite many attempts by manufacturers
and a number of clinical centres to encourage their use.
This relatively low acceptance and use of the devices by
their intended patient users may be due to various rea-
sons. As revealed from the patients’ blogs reported in
this paper, a major barrier to the uptake of PT/INR
self-testing is the cost of both the device and testing
strips [2].
Another factor limiting PT/INR self-testing could be
the availability of a free home testing service undertaken
b yac o m m u n i t yn u r s ei nc e r t a i nc o u n t r i e so ra r e a s
within countries, as reported in the blogs analysed in
this study. This however is more likely to occur where
healthcare as a whole is provided free at the point of
delivery such as through the NHS in the UK but this
might not hold in other cases. The general lack of for-
mal evidence of clinical safety and the effectiveness of
patient self-testing compared to professional testing
could be another limiting factor in the extension of self-
testing [2]. This is likely to be compounded by the
extensive and often well-developed infrastructure of
hospital or clinical testing which, in some respects, self-
testing may be seen as undermining, or indeed be being
undertaken largely outside the monitoring or control of
that infrastructure.
It was interesting to note that blogs’ participants did
not raise any issues relating to the design and usability
of the device and test strips as well as errors or other
problems encountered during PT/INR self-testing. It
might be possible that the participants who used the
equipment never encountered such problems or these
issues were not raised on blog discussion boards. In this
regard, a possible alternative explanation could be that
these issues are already well addressed by the manufac-
turers before the equipment is deployed in the market.
Though reliable self-monitoring devices are available,
there is an urgent need for agreed and widely available
quality assurance mechanisms for self-monitoring [2]. In
addition, there is a need to control pre analytical errors
which occur in PT/INR monitoring at both home and
the hospital [3]; otherwise patients might stop self-
testing for economic, social and psychological reasons.
Another issue that patients raised in their blogs was the
availability of technical services for self-testing device
calibration, which should be timely, regularly and stan-
dardised to ensure safety and confidence in the equip-
ment both by patients and by those professionally
monitoring device use [42].
According to Yang et al [3], manufacturers are
responsible for device calibration because they control
device calibration protocols [43]. However, patients’
blogs show that they have been contacting their health-
care providers for the device calibration, where manu-
facturers have been less active or available in this
respect. Therefore, patients show in the blogs that they
need to know clearly whom to contact for device
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of healthcare provider and device manufacturer, as
determining who should bear the costs associated with
the role.
Research studies have shown mixed findings in relation
to the cost effectiveness of monitoring oral coagulations
[44]. Lafata et al [45] have reported that patient self-
monitoring (PSM) is not cost effective compared to
health professional monitoring (HPM) while Taborski
et al [46], Cheung et al [47] and Regier et al [48] reported
that PSM is indeed more cost effective than the HPM.
Overall, it is clear that further research needs to be
undertaken on this issue to determine finally, what the
position is. However, this study has demonstrated several
reasons why there are likely to be continuing debates
about the cost effectiveness of self-testing of oral coagula-
tions. The issues of selecting and training patients as well
as maintaining devices are critical [2,49]. Personal as well
as social factors are similarly important, and what stands
out from the data is that the notion of an entirely self-
contained process of self-testing, where contact with
manufacturers or healthcare system is minimal, is unli-
kely to materialise. From the patient blogs it is evident
that very frequently there is the need for training (and
retraining), monitoring, calibration, assessment or reas-
surance at all stages of self-testing particularly where a
failure in any one of these areas could have damaging, if
not fatal consequences for patients.
Limitations of this study design
The authors recognise limitations of extracting informa-
tion from blogs and using it for the academic research.
The research design applied in this study used a set of
key words to identify a suitable sample of blogs to collect
the required data. In doing so, some relevant blogs might
have been missed as well as some important issues
regarding self-testing of OAT might have not been dis-
covered through this study design. Therefore, in depth
information about self-testing of OAT can be collected
through other research designs such as the in-person
interviews of an appropriate sample of patients. More-
over, another limitation of blogs is a lack of complete
demographic details of bloggers, as reported in this
study. Therefore, findings of this study may be inter-
preted cautiously and no attempt should be made to gen-
eralise these findings. However, the findings of this study
can be recognised as an exploratory work, which can
help in planning further studies as mentioned earlier.
Conclusions
As indicated in this paper, INR testing currently involves
a very large number of patients. Many of these patients
are older, not least because the conditions, which result
in the need for anticoagulation therapy as well as the
associated INR testing, occur far more frequently with
age. Formal healthcare resources needed for the conti-
nuing care of such patients are substantial. Thus, self-
testing of INR levels should, in principle, substantially
reduce these dedicated resources. Indeed, this argument
is frequently the basis on which both manufacturers of
self-testing devices as well as those concerned with the
deployment of healthcare resources suggest the value of
self-testing could be measured. However, this study,
whilst primarily qualitative rather than quantitative in
nature, suggests that the complexities of developing an
effective self-testing programme are substantial.
Whilst it may be argued, rightly, that the analysis of
Internet blogs is a problematic methodological endea-
vour for charting the exact dimensions of the issues in
developing self-testing programmes, the data suggest the
very wide range of issues that from a patient’s point of
view may determine their initial or continuing use of
self-testing. Of course, some of these issues are very
healthcare system specific, in this case, largely condi-
tioned by the very different systems in the US and the
UK. However, what is more surprising is the commonal-
ity of concerns, which seem to operate, almost indepen-
dent of the healthcare system itself. As at a fundamental
level for patients on anticoagulation therapy INR testing
I Sam a t t e ro fl i f eo rd e a t h( f o rt o ol i t t l eo rt o om u c h
anticoagulation therapy may result in fatal conse-
quences), many of the issues raised have this point at
their core. Self-testing can be liberating from the drud-
gery of operating only with the pattern of (often poor or
inconvenient) service provided by the healthcare system,
as some bloggers have indicated, but, at the same time,
there are frequently concerns about the effectiveness,
reliability and use of self-testing equipment. Moreover,
as appears to be indicated above, such concerns may
not only be expressed by patients but also by healthcare
professionals.
Whilst being very conscious of issues of the exact
representativeness of those who choose to blog, as in
the case of this paper, there is evidence from other stu-
dies to suggest that the range of issues covered in the
blogs is sufficiently broad and all-embracing to give a
consistent and clear picture of the extent of those issues,
which are exercising ‘self-testers’. In this respect, analys-
ing such blogs may prove to be a useful first step in the
preparation of more detailed face-to-face studies in this
area, particularly where an analysis of such blogs proves
both congruent and complementary to other studies
using different methods.
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